Home / Intelligence / Briefs


Digital Competency Report

Our new annual Digital Competency Report assesses 124 in-market biopharma patient brands through the lens of digital execution. The novel study evaluates the brands across five categories and 40 unique metrics to rank each one on a scale from Transformational to Novice. The excerpt, available to the public, offers a look into the rankings. TGaS Omnichannel Solution Members will receive a full report readout that dives into performance by company and therapy, cross data analysis looking at things like spend…

Read Now

Sixty-two Percent of Biopharma Executives Say Their Organization Does Not Prioritize Diversity, Equity and Inclusion When Selecting a Vendor

Waltham, MA, July 29, 2021 — Trinity Life Sciences, a leader in global life sciences commercialization solutions, is sharing findings from its latest TGaS Advisors’ report entitled Diversity, Equity, and Inclusion (DEI): An Emerging, Key Consideration When Selecting Vendors. The report finds that 62 percent of biopharma executives say their organization does not prioritize DEI as one of the top three important reasons in selecting a vendor. However, nearly half of all respondents (48 percent) indicate that DEI has increased…

Read Now

Changes in Third-Party Cookie Management and Their Effects on Pharmaceutical Brands

The elimination of third-party cookies is not a new concept. Safari and FireFox eliminated them a few years back. However, now the largest used browser (Chrome) is joining FireFox and Safari, announcing the imminent removal of third-party cookies in 2022. Organizations are attempting to navigate the impact and identify alternatives. Driven by increased user privacy, Google’s decision will require fundamental changes across media and advertising platforms. The departure of third-party cookies will change the way pharmaceutical companies, in fact all…

Read Now

Transforming the Commercial Model in the Age of COVID-19

As the year began, we couldn’t have foreseen the unprecedented impact the COVID-19 pandemic would have on US and Global enterprises. By mid-March, we were in lock-down, and priorities for Commercial and Medical Affairs organizations in the life sciences industry shifted. Leaders were working feverishly to enable virtual and digital channels to engage with customers as well as internal teams. Companies reached out to TGaS Advisors for our guidance in navigating this uncharted territory, and we stepped up to proactively…

Read Now

Data Management Advisory Brief

Trinity has heard numerous organizations express frustration with their data management provider. Common challenges include quality issues, timeliness and lack of flexibility. Switching to another provider isn’t as hard as you think. In this advisory brief, we outline the top five things to keep in mind if you are considering a switch. Please complete the form to download a copy of our Advisory Brief: Frustrated with Your Current Data Management Provider?…

Read Now

COVID-19 Briefing Series: Impact of COVID-19 on New Product Planning

Trinity explores some of the immediate challenges presented to New Products Planning (also known as Early Commercial Planning or New Product Commercialization) groups. Publication Access Form For more information: Elizabeth MarshallTrinity Life…

Read Now

COVID-19 Briefing Series: Launch in the Age of COVID-19

While COVID-19 is grinding world economies to a potentially disastrous halt, the pharmaceutical and biotech industry continues to move forward at a slower pace. How can companies ensure an agile launch despite the uncertainty and ensure launch success during and in a post-COVID-19 world? About Trinity Life Sciences Trinity Life Sciences is a trusted strategic partner, providing evidence-based solutions for the life sciences. With over 20 years of experience, Trinity is committed to solving clients’ most challenging problems through exceptional…

Read Now

COVID-19 Impact to Biopharma Recruiting, Resourcing, and Culture

In this webinar, Trinity Life Sciences highlights findings from our TGaS Landscape study entitled, “Building Commercial Teams During COVID-19.” This study is based on qualitative interviews with 26 Chief Commercial Officers in the biopharmaceutical industry. We explore how biopharma companies are finding talent, interviewing candidates and building commercial teams under the constraints of working during the COVID-19 pandemic. Please complete the form to watch Trinity Webinar: Building Commercial Teams During COVID-19.…

Read Now

COVID-19 Briefing Series: Telehealth as the New Normal

Highlights from Trinity’s Recent Research Focused on Telehealth Since earlier this year when the COVID-19 virus outbreak began and quickly made its way around the globe, the way in which we operate has changed. Virtual communication for personal as well as business interactionsis on the rise. Publication access form…

Read Now